Back to search

Belgium· BE-AMP-SAM316172-00

Paroxetine EG 20 mg

A paroxetine product containing paroxetine hydrochloride, registered in Belgium by EG. The same ATC class is registered in 19 of our 19 countries.

ATC N06AB05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedParoxetine EG 20 mgATCN06AB05REGISTER NO.BE-AMP-SAM316172-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Paroxetine is registered in 19 of 19 countries.

Countries holding a registration under ATC N06AB05 (paroxetine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 11 of them publish a price we can compare per daily dose

Paroxetine · ATC N06AB05

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paroxetine costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.18 in France to $1.04 in Switzerland — a ×5.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Paroxetine · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.04
  • IT Italy$0.26
  • FR France$0.18
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Paroxetine Hydrochloride
Manufacturer
EG
Country
Belgium (BE)
ATC code
N06AB05
ATC class
Paroxetine
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    7725914
  • be_apb
    3891140
  • be_apb
    3891165

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

505 interactions on record for paroxetine.

Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paroxetine · interactions on record

505 records

  • 26 severe
  • 193 moderate
  • 2 minor
  • 209 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe

75 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paroxetine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paroxetine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ennos, Paroxat
  • Bulgaria · Ксетанор, Парикс
  • Cyprus · Afentral, Arketis
  • Czechia · Arketis, Parolex
  • Germany · Euplix, Paroxat
  • Denmark · Euplix, Euplix Dråber, Orale Dråber, Opløsning
  • Estonia · Arketis, Paroxetin Actavis
  • Spain · Daparox, Frosinor
  • Finland · Optipar, Paroxetin Orion
  • France · Deroxat, Divarius
  • United Kingdom (Northern Ireland) · Paroxetine, Paroxetine Activase Pharmaceuticals
  • Greece · Paroxia, Seroxat
  • Croatia · Paroksetin Pharmas, Seroxat
  • Hungary · Paretin, Parogen
  • Ireland · Parox, Seroxat
  • Iceland · Paxetin Teva, Seroxat
  • Italy · Arzinka, Dapagut
  • Lithuania · Arketis, Paroxetin Actavis
  • Luxembourg · Paroxetine Eg, Paroxetine Viatris
  • Latvia · Arketis, Paroxetin Actavis
  • Malta · Arketis, Paroxetine Aurobindo
  • Netherlands · Parmite, Paroxetine Cf
  • Norway · Paroxetine Oresund Pharma, Seroxat
  • Poland · Arketis, Parogen
  • Portugal · Dropax, Paroxetina Alter Genéricos
  • Romania · Arketis, Paroxetină Teva
  • Sweden · Parocetan, Paroxetin Hexal
  • Slovenia · Paroxat, Seroxat
  • Slovakia · Arketis, Paretin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb05be1a-4dff-46ef-9677-b5629e89b221
GET /v1/drugs/fb05be1a-4dff-46ef-9677-b5629e89b221?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Paroxetine EG 20 mg",
  "name_fr": "Paroxetine EG 20 mg",
  "name_nl": "Paroxetine EG 20 mg",
  "amp_code": "SAM316172-00",
  "strengths": [
    "22.2200",
    "22.2200",
    "20.0000",
    "20.0000"
  ],
  "pack_count": 14,
  "substances": [
    "Paroxetine Hydrochloride",
    "Paroxetine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Paroxetine",
  "authorisation_numbers": [
    "BE316172"
  ]
}

See everything about paroxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.